![]() |
市場調查報告書
商品編碼
1708242
皮膚科準分子雷射市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測Dermatology Excimer Laser Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球皮膚科準分子雷射市場規模達 6.096 億美元,預計 2025 年至 2034 年期間的複合年成長率為 10.2%。這些高度專業化的醫療設備使用高強度紫外線光束針對特定的皮膚區域,提供卓越的精確度,同時將對周圍組織的損傷降至最低。準分子雷射的工作波長為 308 奈米,是治療各種皮膚病的理想選擇。隨著皮膚病患病率的不斷上升,特別是牛皮癬、白斑症和濕疹等皮膚病,對準分子雷射的需求顯著成長。技術進步提高了這些雷射的效率和精度,進一步推動了這一上升趨勢。現在,越來越多的醫療保健提供者和患者開始採用準分子雷射來尋求有效的非侵入性治療選擇。因此,準分子雷射已成為現代皮膚病學的重要工具,為需要高精度治療的皮膚病提供可靠且有針對性的解決方案。
市場分為幾個類別,包括推車式、手持式和桌上型準分子雷射。 2024年,推車式準分子雷射佔45.6%的市佔率。這些設備因其結構堅固、便於攜帶以及能夠將 UVB 光準確地傳送到皮膚的特定區域而備受青睞。該領域的成長可以歸因於雷射設備的技術進步和對皮膚狀況的深入了解,這使得推車式準分子雷射成為各種皮膚病治療的首選解決方案。
市場範圍 | |
---|---|
起始年份 | 2024 |
預測年份 | 2025-2034 |
起始值 | 6.096億美元 |
預測值 | 16億美元 |
複合年成長率 | 10.2% |
在應用方面,準分子雷射市場根據所治療的皮膚狀況進一步細分。例如,牛皮癬在 2024 年佔據了 38.2% 的市場。準分子雷射在治療牛皮癬病變方面特別有效,可將 UVB 光直接傳送到患處,從而促進更快的癒合和恢復。隨著對慢性皮膚病有效治療的需求不斷成長,準分子雷射越來越被認可為患者和醫療保健提供者的首選。
2024 年美國皮膚科準分子雷射市場規模達 2.287 億美元,預計複合年成長率為 10.2%。慢性皮膚病的激增,加上提高效率和安全性的雷射技術的進步,刺激了美國市場的成長。準分子雷射治療具有針對性、非侵入性、精確性和有效性,使其成為解決該地區各種皮膚病問題的首選。隨著該市場的不斷發展,準分子雷射將在未來的皮膚病治療中發揮關鍵作用。
The Global Dermatology Excimer Laser Market generated USD 609.6 million in 2024 and is expected to grow at a CAGR of 10.2% between 2025 and 2034. These highly specialized medical devices use high-intensity ultraviolet light beams to target specific skin areas, offering exceptional precision with minimal damage to surrounding tissue. Operating at a wavelength of 308 nanometers, excimer lasers are ideal for treating various skin conditions. With the increasing prevalence of skin disorders, particularly in dermatological cases like psoriasis, vitiligo, and eczema, the demand for excimer lasers has seen significant growth. Technological advancements, which have enhanced the efficiency and precision of these lasers, have only fueled this upward trend. More healthcare providers and patients are now turning to excimer lasers for effective, non-invasive treatment options. As a result, excimer lasers have become an essential tool in modern dermatology, offering reliable and targeted solutions for skin conditions that require a high degree of precision in treatment.
The market is segmented into several categories, including excimer lasers such as trolley-mounted, handheld, and tabletop devices. In 2024, trolley-mounted excimer lasers accounted for a 45.6% market share. These devices are highly favored due to their robust construction, ease of transport, and ability to deliver UVB light accurately to specific areas of the skin. The growth of this segment can be attributed to both technological advancements in laser equipment and an enhanced understanding of skin conditions, which have made trolley-mounted excimer lasers the go-to solution for a variety of dermatological treatments.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $609.6 Million |
Forecast Value | $1.6 Billion |
CAGR | 10.2% |
In terms of application, the excimer laser market is further divided by the skin conditions being treated. Psoriasis, for example, made up 38.2% of the market share in 2024. Excimer lasers are particularly effective in treating psoriasis lesions, delivering UVB light directly to the affected areas, thereby promoting faster healing and recovery. As the demand for effective treatments for chronic skin disorders continues to rise, excimer lasers are increasingly recognized as a go-to option for patients and healthcare providers alike.
The U.S. Dermatology Excimer Laser Market generated USD 228.7 million in 2024 and is expected to grow at a 10.2% CAGR. The surge in chronic skin conditions, coupled with advancements in laser technology that enhance both efficiency and safety, has spurred the market's growth in the U.S. The targeted, non-invasive nature of excimer laser treatments, which offer both precision and effectiveness, has made them the preferred choice for addressing a wide range of dermatological issues in the region. As this market continues to evolve, excimer lasers are set to play a crucial role in the future of dermatology treatments.